Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Neurotox Res ; 39(5): 1524-1542, 2021 Oct.
Article in English | MEDLINE | ID: mdl-34224102

ABSTRACT

Sevoflurane postconditioning (SPC) has been widely reported to attenuate brain injury after hypoxia-ischemia encephalopathy (HIE) by inhibiting neural necrosis and autophagy. Moreover, recent reports revealed that sevoflurane facilitated hippocampal reconstruction via regulating migration. Yet, it remains unclear whether the promotion of neural migration by SPC repairs the hippocampal injury after HIE. Here, we hypothesize that SPC exerts a neuroprotective effect by ameliorating neuronal migration disorder after HIE and regulating Reelin expression. Furthermore, the downstream Reelin/Dab1 pathway may be involved. The classical Rice-Vannucci model of hypoxia-ischemia was performed on postnatal day 7 rat pups, which was followed by SPC at 1 minimum alveolar concentration (MAC 2.5%) for 30 min. Piceatannol, causing Reelin aggregation in vivo, was used to detect whether Reelin/Dab1 was involved in the neuroprotection effect of SPC. Hippocampal-dependent learning ability tests were conducted to assess the long-term effects on locomotor activity and spatial learning ability. Our findings suggest that hypoxia-ischemia injury inhibited neurons migrated outward from the basal zone of dentate gyrus, disrupted cytoarchitecture of the dentate gyrus (DG), and led to long-term cognition deficits. However, SPC could relieve the restricted hippocampal neurons and repair the hippocampal-dependent memory function damaged after HIE by attenuating the overactivation of the Reelin/Dab1 pathway. These results demonstrate that SPC plays a pivotal role in ameliorating neuronal migration disorder and maintaining normal cytoarchitecture of the DG via inhibiting overactivated Reelin expression. This process may involve overactivated Reelin/Dab1 signaling pathway and spatial learning ability by regulating the Reelin expression which may associate with its neuroprotection.


Subject(s)
Adaptor Proteins, Signal Transducing/antagonists & inhibitors , Cognition/drug effects , Hypoxia-Ischemia, Brain/drug therapy , Malformations of Cortical Development, Group II/drug therapy , Nerve Tissue Proteins/antagonists & inhibitors , Reelin Protein/antagonists & inhibitors , Sevoflurane/administration & dosage , Adaptor Proteins, Signal Transducing/biosynthesis , Animals , Animals, Newborn , Cell Movement/drug effects , Cell Movement/physiology , Cognition/physiology , Hypoxia-Ischemia, Brain/metabolism , Hypoxia-Ischemia, Brain/pathology , Ischemic Postconditioning/methods , Male , Malformations of Cortical Development, Group II/metabolism , Malformations of Cortical Development, Group II/pathology , Nerve Tissue Proteins/biosynthesis , Neurons/drug effects , Neurons/metabolism , Neurons/pathology , Neuroprotective Agents/administration & dosage , Platelet Aggregation Inhibitors/administration & dosage , Rats , Rats, Sprague-Dawley , Reelin Protein/biosynthesis , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...